BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 16270720)

  • 1. Comparative efficacy of cetirizine and fexofenadine for seasonal allergic rhinitis, 5-12 hours postdose, in the environmental exposure unit.
    Day JH; Briscoe MP; Rafeiro E; Ratz JD; Ellis AK; Frankish CW; Chapman D; deGuia EC; Kramer B; Warner C
    Allergy Asthma Proc; 2005; 26(4):275-82. PubMed ID: 16270720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis.
    Day JH; Briscoe MP; Rafeiro E; Hewlett D; Chapman D; Kramer B
    Allergy Asthma Proc; 2004; 25(1):59-68. PubMed ID: 15055564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH; Stern MA; Roi L; Reynolds R; Bousquet J
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH; Briscoe M; Widlitz MD
    J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fexofenadine HCl 60 mg/ pseudoephedrine HCl 120 mg has a 60-minute onset of action in the treatment of seasonal allergic rhinitis symptoms, as assessed in an allergen exposure unit.
    Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
    Allergy Asthma Proc; 2004; 25(5):335-43. PubMed ID: 15603207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of fexofenadine and cetirizine in the treatment of allergic rhinitis].
    López García A; Paz Martínez D; Orea Solano M; Hernández Valencia G; Ramírez García A; Ramírez Ojeda H; Sánchez Medal LF; Soda Mehry A; Velarde Domínguez T; Betancourt Suárez MA; Méndez Vera JL
    Rev Alerg Mex; 2001; 48(6):168-72. PubMed ID: 11802289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis.
    Wahn U; Meltzer EO; Finn AF; Kowalski ML; Decosta P; Hedlin G; Scheinmann P; Bachert C; Rosado Pinto JE; Baena-Cagnani C; Potter P; Simons FE; Ruuth E
    J Allergy Clin Immunol; 2003 Apr; 111(4):763-9. PubMed ID: 12704355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
    Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-four hours of activity of cetirizine and fexofenadine in the skin.
    Purohit A; Duvernelle C; Melac M; Pauli G; Frossard N
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):387-92. PubMed ID: 11345280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF; Widlitz MD; Mitchell DQ; Lumry W; Dockhorn R; Woehler T; Grossman J
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine.
    LaForce CF; Corren J; Wheeler WJ; Berger WE;
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):154-9. PubMed ID: 15328675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis.
    Horak F; Stübner P; Zieglmayer R; Kavina A; De Vos C; Burtin B; Donnelly F
    Int Arch Allergy Immunol; 2001 May; 125(1):73-9. PubMed ID: 11385291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria.
    Simpson K; Jarvis B
    Drugs; 2000 Feb; 59(2):301-21. PubMed ID: 10730552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
    Berkowitz RB; Dockhorn R; Lockey R; Findlay S; Howland WC; Mitchell DQ; Woehler T
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis--a pooled analysis of three studies.
    Meltzer EO; Scheinmann P; Rosado Pinto JE; Bachert C; Hedlin G; Wahn U; Finn AF; Ruuth E
    Pediatr Allergy Immunol; 2004 Jun; 15(3):253-60. PubMed ID: 15209959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK; Gex-Collet C; Wüthrich B
    J Investig Allergol Clin Immunol; 1999; 9(6):351-5. PubMed ID: 10664928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of 30 mg fexofenadine HCl bid in pediatric patients with allergic rhinitis.
    Ngamphaiboon J; Direkwattanachai C; Visitsunthorn N; Vangveeravong M; Tiensuwan M
    Asian Pac J Allergy Immunol; 2005 Dec; 23(4):169-74. PubMed ID: 16572735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis.
    Bachert C
    Clin Ther; 2009 May; 31(5):921-44. PubMed ID: 19539095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.